In today’s recent session, 8.07 million shares of the BioAffinity Technologies Inc (NASDAQ:BIAF) have been traded, and its beta is 2.56. Most recently the company’s share price was $0.26, and it changed around -$0.01 or -4.32% from the last close, which brings the market valuation of the company to $7.32M. BIAF at last check was trading at a discount to its 52-week high of $2.99, offering almost -1050.0% off that amount. The share price’s 52-week low was $0.16, which indicates that the recent value has risen by an impressive 38.46% since then. We note from BioAffinity Technologies Inc’s average daily trading volume that its 10-day average is 0.87 million shares, with the 3-month average coming to 12.25 million.
BioAffinity Technologies Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended BIAF as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight.
BioAffinity Technologies Inc (NASDAQ:BIAF) trade information
Instantly BIAF has been showing red trend so far today with a performance of -4.32% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.3050 on recent trading dayincreased the stock’s daily price by 14.75%. The company’s shares are currently down -71.75% year-to-date, but still down -12.64% over the last five days. On the other hand, BioAffinity Technologies Inc (NASDAQ:BIAF) is 14.24% up in the 30-day period. We can see from the shorts that 1.61 million shares have been sold at a short interest cover period of 0.19 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -10.71%.
BIAF Dividends
BioAffinity Technologies Inc’s next quarterly earnings report is expected to be released on 2025-May-15.
BioAffinity Technologies Inc (NASDAQ:BIAF)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 24.52% of BioAffinity Technologies Inc shares, and 1.80% of them are in the hands of institutional investors. The stock currently has a share float of 2.38%. BioAffinity Technologies Inc stock is held by 17.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 1.5101% of the shares, which is about 0.17 million shares worth $0.37 million.
GEODE CAPITAL MANAGEMENT, LLC, with 0.6111% or 69600.0 shares worth $0.15 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
